“As we mark World AIDS Day on December 1st, despite all the recent setbacks due to the ongoing COVID-19 epidemic, there is hope on the horizon for ending HIV in the United States,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “President Biden is set to release an updated National HIV/AIDS Strategic Plan and several bills have been or are about to be introduced in Congress to establish a national PrEP program to prevent HIV. Additionally, Congress is poised to increase funding for domestic HIV programs for the year ahead. Taken together, these are hopeful signs. However, for these well-intentioned plans to be implemented, much work still needs to occur.”
Bipartisan bill makes drugs more affordable by ensuring copay assistance counts
The “Help Ensure Lower Patient Copays Act” would ban a cruel practice implemented by insurance companies that accept a patient’s copay assistance but does not apply it to the patient’s deductible and out-of-pocket cost obligations. This leaves the patient with potentially thousands of dollars in unanticipated costs.
Senate Appropriations leadership proposes significant increases for domestic HIV programs: Hepatitis programs left flat-funded
The leadership of the United States Senate Appropriations Committee is proposing to significantly increase funding to continue to ramp up efforts to end HIV in the United States. Like the House, the Senate bills include increased funding for the Ending the HIV Epidemic in the U.S. initiative by at least $245 million for domestic HIV testing, prevention, treatment, and research programs. This matches the amount proposed in President Biden’s budget.
From the office of Rep. Bonnie Watson Coleman: Reps. Watson Coleman, Barbara Lee, Schiff, Jones Reintroduce PrEP Assistance Program Act
“HIV+Hepatitis Policy Institute fully supports this bill and urges Congress to swiftly pass it. While there are government programs for people living with HIV and other prevention programs, there isn’t a comprehensive nationwide program for PrEP,” said Executive Director Carl Schmid. “The PrEP Assistance Program Act would help fill that void by providing grants to states, community-based organizations, community health centers, and others to establish and support PrEP programs. Not only would these programs provide PrEP and associated medical services, but also much needed community and provider outreach programs.”
40 patient groups urge HHS to improve drug affordability through standard benefit plans
The HIV+Hepatitis Policy Institute (HIV+Hep) and American Autoimmune Related Diseases Association (AARDA), along with 38 other patient organizations, filed comments earlier this week with the U.S. Department of Health and Human Services (HHS) addressed to Secretary Xavier Becerra that urge HHS to improve the affordability of prescription drugs for patients in the private insurance market through Standard Benefit Plans.